Respiratory Dendritic Cell Subsets Differ in Their Capacity to Support the Induction of Virus-Specific Cytotoxic CD8+ T Cell Responses by Kim, Taeg S. & Braciale, Thomas J.
Respiratory Dendritic Cell Subsets Differ in Their
Capacity to Support the Induction of Virus-Specific
Cytotoxic CD8
+ T Cell Responses
Taeg S. Kim
1, Thomas J. Braciale
1,2*
1Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, United States of America, 2Departments of Microbiology and
Pathology, University of Virginia, Charlottesville, Virginia, United States of America
Abstract
Dendritic cells located at the body surfaces, e.g. skin, respiratory and gastrointestinal tract, play an essential role in the
induction of adaptive immune responses to pathogens and inert antigens present at these surfaces. In the respiratory tract,
multiple subsets of dendritic cells (RDC) have been identified in both the normal and inflamed lungs. While the importance
of RDC in antigen transport from the inflamed or infected respiratory tract to the lymph nodes draining this site is well
recognized, the contribution of individual RDC subsets to this process and the precise role of migrant RDC within the lymph
nodes in antigen presentation to T cells is not clear. In this report, we demonstrate that two distinct subsets of migrant RDC
- exhibiting the CD103
+ and CD11b
hi phenotype, respectively - are the primary DC presenting antigen to naı ¨ve CD4
+ and
CD8
+ T lymphocytes in the draining nodes in response to respiratory influenza virus infection. Furthermore, the migrant
CD103
+ RDC subset preferentially drives efficient proliferation and differentiation of naive CD8
+ T cells responding to
infection into effector cells, and only the CD103
+ RDC subset can present to naı ¨ve CD8
+ T cells non-infectious viral vaccine
introduced into the respiratory tract. These results identify CD103
+ and CD11b
hi RDC as critical regulators of the adaptive
immune response to respiratory tract infection and potential targets in the design of mucosal vaccines.
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Introduction
A critical initial event in the induction of adaptive immune
response is the uptake and presentation of antigen by dendritic
cells (DC) to adaptive immune cells. DC reside within organized
secondary lymphoid organs (e.g., spleen, lymph nodes, Peyer’s
Patches) and also localize at body surfaces (e.g., the skin,
gastrointestinal and respiratory tracts) where they sample the
external environment for foreign antigens and invading infectious
microorganisms [1,2,3,4]. At body surfaces, DC normally display
an immature phenotype. Inflammatory stimuli such as infection
trigger a sequence of maturation events resulting in the migration
of the activated antigen-bearing DC to secondary lymphoid
organs, e.g., lymph nodes (LN), via lymphatic vessels draining the
inflamed body surface along a chemokine-dependent gradient
[5,6]. It is within the draining lymph nodes (DLN) that adaptive
immune responses are initiated [7,8]. The DC populations present
in DLN include not only migrant antigen-bearing DC and DC
resident in the lymphoid organs [3], but also DC in the circulation,
i.e., plasmacytoid DC (pDC) [9,10,11] and Gr-1
+ monocytic DC
(MoDC) derived from circulating Gr-1
hi monocyte precursors
[12,13,14], which enter the DLN directly from the circulation or
first enter the peripheral sites of infection in response to
inflammatory stimuli. After differentiation/maturation, these
inflammation-induced DC can also capture antigens at the sites
of infection and migrate to the DLN.
DC found both within lymphoid organs and in peripheral tissues
are composed of multiple cell subsets [2,3]. The subsets are defined
based largely on the differential expression of specific cell surface
markers, but also on the anatomic distribution of particular DC
population and on the role or function of the DC subset as innate
immune effector cells or in the induction of adaptive immune
responses. For example, CD8aa
+ DC found in secondary lymphoid
organs are believed to play a dominant role in cross-presentation of
non-replicating antigens, e.g., soluble proteins, to naı ¨ve CD8
+ T
cells [15,16]. In the normal (non-inflamed) respiratory tract, several
distinct subsets of RDC have been defined [17,18,19,20]. RDC
form an interdigitating network along the epithelium and mucosa of
large (conducting) and small airways. They also reside as well
throughout the lung parenchyma and occasionally within airways.
Recently, two subsets of the CD11c
hi MHC II
hi RDC with
anatomically distinct distributions have been identified [19]: one of
the RDC subsets is defined by expression of the aE integrin CD103
(CD103
+ RDC) and preferentially localizes to airway mucosa (and
pulmonary vessels); the second subset, CD103
2CD11b
hi DC
(CD11b
hi RDC), localizes to the submucosa and the lung
parenchyma. Recent evidence suggests that different RDC subsets
may be involved in the induction of T cell responses in the
respiratory tract [19,21,22], but role of these two MHC II
hi RDC
subsets as well as the contribution of the more prominent Gr-1
+
monocytic DC (MoDC) in the host response to respiratory infection
is largely unknown.
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triggers accelerated migration of RDC out of the respiratory tract
into the DLN and induces a vigorous CD4
+ and CD8
+ T cell
responses [7,8,23,24]. The contribution of RDC in general and
specific subsets of RDC in viral antigen presentation to and
activation of naı ¨ve T cells is not well understood. Several lines of
evidence, however, suggest that tissue DC, such as RDC, in
response to infection or inflammation may primarily serve in
antigen transport to the DLN where LN-resident DC acquire
antigen from migrant tissue-derived DC and cross-present it to T
cells [7,25,26]. In this report, we characterized the DC residing in
the respiratory tract – before and after influenza infection – and
assessed the ability of specific subsets of migrant RDC to activate
influenza virus-specific CD8
+ and CD4
+ T cells in response to
infection and non-infectious virus vaccine introduced into the
respiratory tract.
Results
Respiratory dendritic cell subsets and virus infection
DCs are found both in lymphoid organs and in peripheral sites,
e.g. skin, lungs, etc., and are composed of distinct subsets. We
employed a 6 color flow-cytometric strategy to identify RDC
subsets among the heterogeneous population of CD45
+CD11c
+
cells in the normal (non-inflamed) and the infected murine
respiratory tract (Fig. S1). Alveolar macrophages are the dominant
(60%–70%) CD11c
+ cell subset in the normal lung, and are
identified by Siglec F expression [19,27] as well as by their high
side scatter and high autofluorescence [28] resulting in an
apparent moderate high levels of MHC class II expression (Fig.
S1 A, B).
We identified four subsets of DC among the CD11c
+ Siglec F
2
cells in the normal lung based on the expression level of MHC
Class II and the presence of distinct cell surface markers. These
include: 1) a small number of B220
+Gr-1
+MHC II
lo plasmacytoid
DC (pDC) (Fig. S1A - panel e) and 3 more abundant RDC subsets,
2) CD103
+MHC II
hiCD11b
neg-hi DC (designated CD103
+ RDC
hereafter, Figs. 1A and S1A - panel f); 3) CD103
2MHC II
hi
CD11b
med-hi DC (designated CD11b
hi RDC, Figs. 1A and S1A -
panel h); 4) CD103
2MHC II
neg-med CD11b
hi monocytic DC
(designated MoRDC, Figs. 1A and S1A - panel g). These latter 3
RDC subsets also differed in size, light scatters, and expression of
various activation/differentiation markers (Fig. S1D and not
depicted) reinforcing the view that the cells may be distinct
RDC subsets.
Since the MoRDC are the predominant RDC subset, we
considered this RDC subset to likely play a predominant role in
antigen uptake and presentation in the respiratory tract particu-
larly in response to a strong inflammatory stimulus such as virus
infection. However, two subsets of RDC, the CD103
+ RDC and
CD11b
hi RDC were also potential candidates in antigen uptake
and recognition because of their preferential localization to the
airway mucosa of epithelium and the lung submucosa/parenchy-
ma, respectively [19].
To monitor the relative efficiency with which these distinctive
RDC subsets can take up antigen delivered into the respiratory
tract, we use the standard approach of delivering fluorescein-tagged
ovalbumin into the normal (uninfected) mouse respiratory tract by
Figure 1. DC subsets in the normal and influenza-infected lung. (A and C) Conventional RDC subsets in the normal and influenza-infected
lung. Hematopoietic origin cells in the lung suspensions are identified as CD45
+. Among the CD45
+CD11c
+ cells, the highly auto-fluorescent alveolar
macrophages (AM) and B220
+ plasmacytoid DC are excluded from further analyses (see Fig. S1 A and B for gating and identification strategy). CD103
+
RDC (f), MoRDC (g) and CD11b
hi RDC (h) in the uninfected (left) or infected (at d2 p.i., right) lung are identified (A) and enumerated (C) at indicated
days p.i. (B) Ability of RDC subsets to take up soluble antigens in vivo. Mice are given i.n. FITC-labeled ovalbumin (FITC-Ova) or unlabeled Ova proteins
1 hr prior to sacrifice. The amounts (%) of FITC-Ova taken up by RDC subsets are compared to those of ova, and the numbers in the inserts indicate
mean fluorescent intensity (MFI) of FITC-Ova (n.3).
doi:10.1371/journal.pone.0004204.g001
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of this antigen by the four RDC subsets was evaluated by flow
cytometry. As early as one hour post ovalbumin administration
(Fig. 1B), uptake of the antigen by the RDC was demonstrable with
the CD103
+ RDC and the CD11b
hi RDC exhibiting the highest
efficiency. As discussed below for migrant RDC in the draining
lymph nodes, the tagged ovalbumin was localized in endocytic
vesicles within the RDC as expected for immature DC surveying
and taking up antigen at peripheral sites [1]. Of note, CD103
+ and
CD11b
hi RDC but not MoRDC or pDC, express high levels of
costimulatory ligands and antigen presenting molecules (i.e., CD1d
and MHC class II), and lack the co-inhibitory ligand B7-H1 (Fig.
S1D and not depicted). These properties of the CD103
+ and
CD11b
hi RDC subsets would make them attractive candidates to
serve as effective antigen presenting cells.
Following i.n. influenza (A/PR/8/34) infection, these RDC in
the infected lungs retain the markers characteristic of the
individual subsets at early times post infection, i.e., days 1–2
(Fig. 1A and S1D) and remain distinguishable at least up to d5 p.i.
(not depicted). However, influenza infection results in a gradual
but significant increase in the absolute number of CD11b
hi RDC
and MoRDC infiltrating the lungs while the CD103
+ RDC
numbers are minimally increased (Fig. 1C).
CD103
+ and CD11b
hi DC subsets accumulate in the
mediastinal lymph nodes after respiratory influenza virus
infection
Distinct subsets of DC have been identified in the mediastinal
lymph nodes (MLN) draining the murine lungs. RDC which have
migrated to the MLN either constitutively from the normal (non-
inflamed) lungs or in response to pulmonary inflammation/
infection are believed to contribute to the DC population found in
the MLN, but the contribution of the individual subsets of migrant
RDC to the expanded population of DC found in the MLN
following respiratory infection has not been clearly defined. We
analyzed the DC populations liberated from the normal MLN and
from the MLN undergoing sub-lethal influenza infection by two
methods, mechanical disruption on or enzymatic digestion.
In the normal lymph node, DC displaying CD103
+ or CD11b
hi
phenotype are minimally represented and DC with the Gr-1
2
MHC class II
int phenotype of MoDC are the dominant DC
population by either method of lymph node cell dispersion (Fig. 2B
and S2). Following enzymatic digestion [2,7], however, a
characteristic subset of MHC class II
+ CD8aa
+ node resident
DC is also demonstrable among the CD11c
+ cells in the lymph
node (Fig. S3A). Following i.n. infection there is the expected
increase [7] in the total number of CD11c
+ cells in the MLN
(Fig. 2A and S3A). Based on cell surface marker expression to
distinguish DC subsets, CD103
+ and CD11b
hi DC were readily
demonstrable by d3 p.i. along with a Gr-1
+ DC population
expressing cell surface markers characteristics of inflammatory
monocytic dendritic cells, i.e. Gr-1
+ MoDC (Figs. 2B and S2).
pDC numbers in the MLN increased only modestly over this
period (not depicted). It is noteworthy that high-level expression of
costimulatory ligands was largely restricted to the accumulating
CD103
+ and CD11b
hi DC and the chemokine receptor CCR7
was also selectively expressed only on these 2 DC subsets (Fig. 2C).
By contrast, the CD8aa
+ node resident DC likewise increased in
number only modestly during the first 3 days of infection (Fig. S3A
and not depicted) and while expressing highest levels of CD11c,
this DC subset expressed lower levels of costimulatory ligands than
aforementioned DC subsets (Fig. S3B). As observed for the lung
resident RDC, these several DC subsets found in the MLN
following infection had distinct size, cellular complexity and
surface marker differences (Fig. S4) suggesting that they indeed
represent distinct CD11c
+ cell subsets.
The expression of high levels of MHC molecules and
costimulatory ligands, characteristics of mature DC [1], by the
CD103
+ and CD11b
hi DC (Fig. 2C) would make them likely
candidates to serve as potent APC for naı ¨ve virus-specific T cells.
It is of interest that these two DC subsets in the draining MLN also
express CD8a (and b) (Figs. 2C, S4A, and not depicted). However,
unlike the lymph node-resident CD8aa
+ which constitutively
expressed this molecule (Fig. S4A), companion studies analyzing
the lymph node DC subsets in infected T lymphocytes deficient
Rag1
2/2 mice suggest that the CD8a displayed by these two
MHC II
hi DC subsets is most likely acquired as CD8a/b
heterodimers from T cells within the draining MLN via
trogocytosis ([29,30], and not depicted).
Figure 2. Progressive accumulation of CD103
+ DC and CD11b
hi
DC in the lung-draining lymph nodes of influenza-infected
mice. (A) Accumulation of CD11c
hiMHC II
hi DC in the MLN after
influenza infection. Representatives of total CD11c
+ cells in the MLN of
influenza-infected mice at indicated days p.i. are shown. (B) Accumu-
lation of three major DC subsets in the MLN of influenza-infected mice.
CD103
+ DC (CD11c
hiMHC II
hiCD103
+CD11b
+/2, group I), CD11b
hi DC
(CD11c
hiMHC II
hiCD103
2CD11b
hi, group II)a n dG r - 1
+ MoDC
(CD11c
loMHC II
loCD103
2Gr-1
+CD11b
hi, group III) are highly represented
in the MLN at d3 p.i. (right panel) compared to those in uninfected
animals (left panel) (see gating strategy in Fig. S2). (C) Phenotypic
features of DC subsets in the MLN of influenza-infected mice at d3 p.i.
Surface marker expression on CD103
+ DC (Group I, gray), CD11b
hi DC
(Group II, white) and Gr-1
+ MoDC (Group III, black) identified in the
MLN of infected (d3 p.i.) mice (right panel in B) is examined after
staining with indicated mAbs. Vertical lines (|) indicate the median
values of surface staining with isotype-matched control antibodies.
doi:10.1371/journal.pone.0004204.g002
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+ and CD11b
hi DC subsets in the
draining MLN during respiratory influenza virus infection
Since the MHC II
hi CD103
+ and CD11b
hi RDC as well as the
MoRDC were present in both the normal and infected lungs, the
accumulation of DC with the same phenotypes in the MLN
draining infected lungs most likely reflected the accelerated
migration of these DC subsets from the lungs to the draining
nodes in response to infection rather than recruitment of DC
progenitors from the bone marrow to the MLN or the de novo
differentiation/maturation of CD103
2CD11b
lo/med LN-resident
DC into these respective DC subsets upon infection. To determine
a potential link between the lung-residing RDC and these MHC
II
hi DC accumulating in the MLN during infection, we first
examined the effect of i.n. administration of soluble FITC-Ova at
d2 p.i. on fluorescenated protein displayed by DC subsets in the
MLN 24 hr later. We chose this time frame for labeled antigen
administration and cell analysis because this time frame coincided
with the rapid accumulation of these two MHC II
hi DC subsets in
the MLN (see below). Therefore, over this 24 hr time frame there
would be sufficient time for cells in the infected lungs including
RDC subsets to take up antigen and then migrate from infected
lung to the MLN. We found that the two MHC II
hi DC subsets,
CD103
+ (44%, Fig. 3A - I) and CD11b
hi (31%, Fig. 3A - II) DC,
and the Gr-1
+ MoDC (53%, Fig. 3A - III) were FITC
+, consistent
with the likely lung-origin of these DC populations. Of note,
confocal images of FITC-Ova
+ cells in the MLN revealed that
FITC-Ova protein is localized within intracellular organells (Fig.
S5), indicative of endo/phagocytosis, rather than diffuse cell
surface binding, and therefore consistent with the concept that
FITC-Ova was directly taken up by RDC via endo/phagocytosis
prior to their migration into the MLN from the lungs.
In companion experiments we determined whether any of these
DC populations found in the MLN displays intracellular expression
of influenza nucleoprotein (NP) by flow-based analysis. This analysis
Figure 3. Sources of DC subsets in the MLN of influenza-infected mice. (A and B) Acquisition and transportation of FITC-Ova (A) or viral
proteins (B) by lung-residing DC into the MLN of infected mice. (A) Fluorescent (FITC)-tagged or unlabeled Ova proteins were i.n. instilled into
influenza-infected mice at d2 p.i. One day later, DC subsets in the MLN of the Ova-instilled infected mice are examined for the uptake (%) of FITC-Ova.
(B) The specific % NP
+ DC subsets in the MLN of infected mice at d3 p.i. is examined after intracellular staining for viral nucleoprotein (NP). (C)
Examination of local proliferation of DC subsets in the MLN of infected mice. DC isolated from the MLN of i.n. infected mice at d3 p.i. are intracellularly
stained for an nuclear antigen Ki-67. Ki-67 staining on CD8
+ T cells isolated from MLN of infected mice at d7 p.i. are depicted as a positive control. (D
and E) Accumulation of CD11b
hi DC and CD103
+ DC in the MLN of infected mice requires the presence of the corresponding counterparts in the lung.
(D) Naı ¨ve DTR mice are instilled i.n. with DTx (lower panel) or vehicle alone (top panel), and depletion of the CD11c
+ RDC subsets in the lung is
examined 48 hr later (n.5). (E) DC subsets in the MLN of influenza-infected mice are identified at d3 p.i. in the DTR mice i.n. given either DTx or PBS
one day prior to infection (n.10).
doi:10.1371/journal.pone.0004204.g003
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+ DC were the predominant infected - NP
expressing - cell type in the MLN (Fig. 3B). This is consistent with our
recently published findings [31] that the CD103
+ RDC subset is most
susceptible to influenza infection in vivo and in vitro. Although the
diffuse intracellular pattern (cytoplasmic as well as nuclear) of
influenza NP expression in the CD103
+ DC from the MLN at d3 p.i.
mimics expression profile of this viral protein in CD103
+ RDC
infected directly ex vivo (Fig. S5), NP
+ cells represented only a fraction
of the CD103
+ DC isolated from the draining nodes. We cannot
exclude the possibility that the majority of the CD103
+ DC in the
MLN may have acquired influenza viral antigens including NP from
infected cells in the respiratory tract prior to the migration of the
RDC into the draining nodes. We further determined that the
accumulation of three major DC subsets and in particular the MHC
II
hi CD103
+ and CD11b
hi DC in the MLN of infected animals was
not due to recent local cell proliferation, as less than 5% of these DC
subsets had undergone recent cell division as determined by the
expression of the nuclear antigen Ki-67, a marker for recent cell
proliferation [32] (Fig. 3C); and administration of the thymidine
analog BrdU continuously during the first 3 days of infection resulted
in a fraction (,30%) of CD103
+ and CD11b
hi DC incorporating this
analog into DNA (Fig. S6A).
To more directly determine the contribution of the lung-residing
CD103
+and CD11b
hi RDC subsets to the corresponding DC subsets
accumulating in the MLN in response to respiratory virus infection,
we exploited the transgenic (tg) mice expressing the non-human
primate diphtheria toxin (DTx) receptor (DTR) driven off the murine
CD11c promoter [33]. Administration of DTx to the DTR mice
results in a toxin dose- and CD11c expression level-dependent
depletion of CD11c
+ DC with CD11c
hi cells most sensitive to the
lowest toxin doses. We found that the local (i.n.) administration of the
low dose of DTx to DTR mice immediately prior to i.n. influenza
infection resulted in the preferential elimination of the two CD11c
hi
DC subsets, the MHC II
hi CD103
+ and CD11b
hi RDC from the
respiratory tract (Fig. 3D) and also inhibited the accumulation of the
CD103
+ and CD11b
hi DC subsets in the MLN after infection, with
only a modest effect on Gr-1
+ MoDC accumulation (Fig. 3E and Fig.
S6B). Of note, high dose i.n. DTx administration resulted in the
depletionofthesetwoCD11c
hiR DCs ubs etsasw ellasM oR DCf r om
the lungs of the DTR mice and also partial depletion of LN DC from
the MLN (not depicted).
These findings, suggesting the lung origin of the CD103
+ and
CD11b
hi DC subsets accumulating in the MLN, were further
supported by studies employing CCR7
2/2 mice. The chemokine
receptor CCR7 plays an essential role in the migration of DC from
peripheral sites to lymphoid organs [5,6] and is expressed by the
CD103
+ and CD11b
hi DC subsets, but not the Gr-1
+ MoDC in
the draining MLN of infected mice (Fig. 2C). CCR7
2/2 mice
exhibit a normal component of lung-residing CD103
+ and
CD11b
hi RDC ([34] and not depicted) but these two DC subsets
(unlike Gr-1
+ MoDC) failed to accumulate in the MLN of
influenza-infected CCR7-deficient mice (Fig. S6 C, D). Taken
together, these data suggest that the accumulation of CD103
+ and
CD11b
hi DC in the MLN of influenza-infected mice results
largely, if not exclusively, from infection-induced migration of
their counterparts present in the lungs rather than through
recruitment of circulating DC progenitors or proliferative
expansion/conversion of resident cells in the MLN.
Tempo of migrant respiratory DC accumulation and
antigen transport into the MLN during respiratory viral
infection
In view of the above findings implicating the lung as the site of
origin of the CD103
+ and CD11b
hi DC subsets accumulating in
the draining MLN of influenza-infected mice (as well as at least
some of the Gr-1
+ MoDC in the MLN), it was of interest to
examine the kinetics of accumulation of these distinct DC subsets
in the MLN, as a basis for establishing if one or more of these DC
subsets may play a critical role in antigen delivery and/or
presentation to adaptive immune cells responding in the MLN (see
below). To this end, we enumerated the number of each of these 3
DC subsets present in the MLN before and at various times after
i.n. influenza virus infection. As observed in Figure 4 A and B, the
time course of DC accumulation in the MLN differs for each DC
Figure 4. Kinetics of the accumulation of three major DC
subsets in the MLN of influenza-infected mice. (A and B) Mice
were i.n. infected with influenza, and at various days p.i., Gr-1
+ MoDC
(%), CD11b
hi DC (e) and CD103
+ DC (q) in the MLN of the infected
mice are identified (as shown in Fig. S2) and enumerated (A). The
magnitude of DC subsets accumulated in the MLN from d0–2 p.i. in (A)
is expanded in (B) (mean6SD; n=4–8 mice/group). (C) Kinetics of the
accumulation of NP
+ DC subsets in the MLN of influenza-infected mice
from d1 to d5 p.i. The % NP
+ DC subsets – Gr-1
+ MoDC (%), CD11b
hi DC
(e), and CD103
+ DC (q) – are represented after subtracting that of
non-specific staining with an irrelevant mAb (mean6SD; n=4–5 mice/
group).
doi:10.1371/journal.pone.0004204.g004
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the MLN increase between d1–2 p.i. (Fig. 4B), they differ in their
days of peak accumulation with CD103
+ and CD11b
hi DC
reaching a peak at d3 and 6 p.i., respectively. The latter
accumulate in the MLN at higher magnitude, reminiscent of the
tempo of CD103
+ and CD11b
hi DC accumulating in the lungs at
an early infection (d 1–3 p.i., Fig. 1C). The numbers of these two
DC subsets progressively decrease after peak accumulation, but
remain at a relatively high level by 1.5–2 wks p.i. On the other
hand, a more robust accumulation of Gr-1
+ MoDC with faster
tempo, peaking at d4 p.i., was observed. Following a gradual
decrease after their peak again, the Gr-1
+ MoDC are minimally
detectable by 2 wks p.i. We also examine the kinetics of expression
of the influenza NP by these three DC subsets in the MLN
(Fig. 4C). NP
+ cells were largely restricted to this CD103
+ DC
subset and expression of the NP by the CD103
+ DC subset was
most prominent early in infection, i.e. greatest at d2 p.i. NP
+ DC
were not detectable in the MLN after day 5 of infection (not
depicted).
CD103
+ and CD11b
hi RDC are required for the activation
of antigen-specific naı ¨ve CD8
+ T cells in the MLN
The Gr-1
+ MoRDC were the most abundant RDC population
both in the influenza infected lungs and in the draining the MLN,
and would therefore be expected to play the most prominent role
in the activation of antigen-specific T cells in the MLN through
viral antigen delivery to DC resident in the MLN and/or by acting
directly as APC. However, because they expressed high levels of
MHC molecules and costimulatory ligands as well as their ability
to take up antigen in the infected respiratory tract, the CD103
+
and CD11b
hi RDC also had the potential to serve as APC after
their migration to the draining MLN (Fig. 2C). To determine the
contribution of lung-resident CD103
+ and/or CD11b
hi RDC to
the induction of an in vivo adaptive immune response in the
draining MLN following influenza infection, we examined the
impact of elimination of CD103
+ and CD11b
hi RDC from the
respiratory tract on the activation and proliferation of virus-
specific naı ¨ve CD8
+ T cells in the DTR model.
Naı ¨ve CSFE dye-labeled influenza hemagglutinin (HA) specific
Clone 4 (CL-4) TCR tg CD8
+ T cells were transferred into DTR
recipients, followed sequentially at 24 hr intervals by low dose i.n.
administration of DTx to selectively eliminate these two RDC
subsets and then i.n. influenza infection. As reported previously
[8,35], and demonstrated here (Fig. S7), adoptively transferred
CSFE-labeled CL-4 T cells vigorously proliferate in the MLN
between days 3 and 4 of infection of wild type control (PBS
treated) DTR mice (Fig. 5 A, B). By contrast, ablation of these 2
CD11c
hi MHC II
hi RDC subsets results in the near complete
absence of CD8
+ T cell proliferation/expansion in the draining
MLN (Fig. 5 A, B). Low dose i.n. DTx administration did not
adversely affect the antigen presenting capacity of DC in the
draining MLN, as the naı ¨ve CL-4 T cells vigorously proliferated in
the MLN of DTx-treated DTR recipients infected with influenza
virus by the intravenous route (Fig. 5 C, D), and DTx
administration into the respiratory tract did not significantly affect
the number of total CD11c
+ cells in the MLN when examined at
48 hr post DTx treatment (not depicted).
The critical role of one or both of these migrant RDC subsets in
T cell activation was further substantiated in studies employing
dye-labeled CCR7
+/+ CL-4 T cells transferred into CCR7
2/2
recipients. After i.n. infection, there was a markedly reduced
proliferative expansion of the CL-4 T cells in the MLN of the
CCR7-deficient mice (Fig. S8A) whose lung-residing CD103
+ and
CD11b
hi DC are unable to do emigrate out of the respiratory tract
in response to virus infection (Fig. S6 C, D). Since the architecture
of secondary lymphoid organs, e.g. lymph nodes, is abnormal in
CCR7-deficient mice, the reduced CD8
+ T cell proliferation in the
MLN of these animals could result from a defect in the interaction
between naı ¨ve T cells and lymph node-resident DC. To assess this
possibility we examine the capacity of the naı ¨ve TCR transgenic
CD8
+ T cells to respond in the MLN after i.v. administration of
infectious influenza virus. Influenza infection by the intravenous
route did not affect proliferative expansion of the CCR7-
competent CL-4 CD8
+ T cells in the MLN of the CCR7-deficient
host (Fig. S8B), suggesting that the absence of the CCR7 receptors
does not alter the ability of LNDC to interact with and activate
naı ¨ve CD8
+ T cells, at least under conditions of intravenous virus
infection.
Migrant CD103
+ and CD11b
hi RDC in the MLN differ in
their ability to stimulate the activation and differentiation
of naı ¨ve virus-specific CD8
+ T cells into effector T cells
The above findings implicated one or both of the two migrant
RDC subsets found in the MLN after respiratory virus infection as
critical for the induction of anti-viral T cell responses presumably
through their capacity to transport the viral antigen to the draining
MLN and possibly to directly serve as APC for naı ¨ve T cells. To
better define the role of these migrant RDC subsets as well as the
other DC subsets found in the MLN after infection in the antigen
presentation to naı ¨ve T cells, we first isolated (after mechanical
Figure 5. The CD11b
hi and CD103
+ RDC subsets are required for the induction of optimal proliferative expansion of virus-specific
CD8
+ T cells responding to respiratory influenza virus infection in vivo. (A–D) Ablation of both lung-residing CD11b
hi and CD103
+ DC
subsets prior to infection resulted in a near absence of virus-specific naı ¨ve CL-4 CD8
+ T cell proliferation in response to respiratory (A and B), but not
intravenous (C and D), influenza virus infection. Following CFSE-labeled CL-4 CD8
+ T cell transfer into DTR mice, DTx (or PBS) is administered i.n. one
day prior to infection. Four (i.n.) or 3 (i.v.) days after virus infection, the division profiles of CL-4 T cells (A or C) and total recovery of the number of CL-
4 T cells (left in B or D) and total cellularity (right in B or D) in the MLN of infected DTR mice were determined (mean6SD; n=4–6).
doi:10.1371/journal.pone.0004204.g005
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+ DC populations (i.e.,
primarily of CD103
+ DC, CD11b
hi DC, Gr-1
+ MoDC and a
smaller number of B220
+ pDC) from the MLN of influenza-
infected mice at d3 p.i. (Fig. S9). We co-cultured these DC subsets
with CSFE-labeled influenza HA-specific naı ¨ve TCR tg CD8
+ or
CD4
+ T cells to evaluate the capacity of these LN-derived DC
subsets to drive naı ¨ve T cell activation/differentiation.
We found that B220
+ pDC fail to activate either naı ¨ve CD4
+ or
CD8
+ T cells. By contrast, the dominant Gr-1
+ MoDC could
stimulate naı ¨ve CD4
+ T cells, albeit to a modest extent, and CD8
+
T cells minimally (Fig. 6A). However, both pDC and Gr-1
+
MoDC could trigger tg CD8
+ T cell proliferation when pulsed
with the pre-processed epitope peptide (Fig. S10). By contrast,
either CD103
+ or CD11b
hi DC isolated from the MLN of infected
mice could support CD4
+ T cell activation, proliferative expansion
(Fig. 6 A, B) and differentiation into effector cytokine-producing
cells (Fig. S11) with comparable efficiency. These two DC subsets,
however, did differ in their ability to trigger naı ¨ve CD8
+ T cell
activation and expansion. While both DC subsets could activate
naı ¨ve CD8
+ T cells, the CD103
+ DC activated a larger fraction of
the naı ¨ve CD8
+ T cells (Fig. 6A) and triggered more extensive
expansion and increased recovery of responding T cells than the
CD11b
hi DC (Fig. 6B). This difference in the efficiency of naı ¨ve
CD8
+ T cell stimulation by the two DC subsets was also evident
when the differentiation state of the responding T cells was
examined. The expression of the cytolytic T lymphocyte effector
molecules, granzyme B and interferon-c, but TNF-a, were
preferentially elevated in responding CD8
+ T cells stimulated by
the CD103
+ DC (Fig. 6C).
CD8aa
+ LNDC have been previously reported to be an
important APC for stimulation of influenza-specific naı ¨ve CD8
+ T
cells through the uptake and presentation of viral antigen delivered
to the MLN by migrant RDC [7]. Elimination of the CD103
+ and
CD11b
hi RDC from the respiratory tract (by i.n. DTx adminis-
tration) or the inability of these RDC to migrate (CCR7
deficiency) to the MLN would result in the failure of viral antigen
delivery to the MLN and as of consequence the inability of
CD8aa
+ LNDC to capture viral antigen and activate naı ¨ve CD8
+
T cells. When the CD8aa
+ LNDC were isolated from the draining
MLN at d3 p.i. and separated from the CD103
+ and CD11b
hi
migrant RDC (also CD8a
+, albeit at a lower level), compared to
the two migrant CD11c
hi MHC II
hi subsets, this LNDC subset
exhibited only modest antigen presenting activity comparable to
that of the migrant Gr-1
+ MoDC (Fig. S12A), but could present
when peptide pulsed (Fig. S12B).
Certain DC subsets appear to be specialized to take up non-
infectious antigenic materials, process and present such antigens
along the MHC class I presentation pathway to naı ¨ve CD8
+ T
cells via ‘cross-presentation’ [36,37,38]. Cross-presentation has
been implicated as the mechanism to allow antigen, such as soluble
proteins, as well as viruses, which do not infect DC, and tumor cell
antigens to stimulate CD8
+ T cell responses [38]. To investigate
cross-presentation of influenza virus by the migrant RDC we
introduce non-infectious intact influenza virion vaccine into the
lungs by the i.n. route and examined the capacity of the DC
subsets isolated from the MLN of vaccine treated at donors to
stimulate directly ex vivo virus-specific naı ¨ve CD4
+ and CD8
+ T
cells. We found that, similar to infectious virus, non-infectious
virions were processed and presented to naı ¨ve CD4
+ T cells by the
CD11b
hi DC and the CD103
+ DC with comparable efficiency
(Fig. 6D). By contrast, the CD103
+ DC preferentially (if not
exclusively) presented peptides derived from in vivo airway
processing of non-infectious virions to naı ¨ve CD8
+ T cells and
trigger T cell proliferation (Fig. 6D).
Figure 6. Airway-derived migrant CD103
+ DC in the inflamed MLN are superior in presenting or cross-presenting influenza virus
antigens to naı ¨ve CD8
+ T cells. (A–C) Efficiency of DC subsets in the MLN of infected animals to stimulate naı ¨ve either CD8
+ or CD4
+ T cells after
intranasal infection with infectious influenza virus. DC subsets isolated from the MLN of mice infected 3 d earlier with influenza virus were co-cultured
with CFSE-labeled HA-specific naı ¨ve TCR tg CD8
+ or CD4
+ T cells for 4 days. Proliferation profile (A) or total recovery (B) of viable CD8
+ or CD4
+ T cells
stimulated by the MLN-derived DC subsets are shown (mean6SD; n=5). Effector functions of CD8
+ T lymphocytes stimulated by either CD11b
hi DC
or CD103
+ DC are examined at d4 co-culture (C). (D) Efficiency of DC subsets in the MLN to stimulate naı ¨ve CD8
+ or CD4
+ T cells after intranasal
administration of non-infectious influenza virions. DC subsets isolated from the MLN of mice inoculated 3 d earlier with inactivated influenza virus
were co-cultured with CFSE-labeled HA-specific naı ¨ve TCR tg CD8
+ or CD4
+ T cells for 4 days. Representatives of proliferation profile of T cell subsets
are depicted (n=3).
doi:10.1371/journal.pone.0004204.g006
DC Subsets/T Cell Responses
PLoS ONE | www.plosone.org 7 January 2009 | Volume 4 | Issue 1 | e4204Discussion
DC found at peripheral body sites such as mucosal surfaces or
the skin are not a uniform population, but rather exist as distinct
cell subsets which differ in the expression of certain cell surface
markers. While the functional significance of these DC subset
differences is poorly understood, different DC subsets are believed
to play distinct roles in the induction and expression of innate and
adaptive immune responses [1,39]. In this report, we demonstrate
that two distinct subsets of DC in the murine respiratory tract
displaying the CD103
+CD11b
+/2 (CD103
+) and the
CD103
2CD11b
hi (CD11b
hi) cell surface phenotypes are the
primary antigen presenting cells, which take up viral antigen
and migrate to the draining MLN to initiate the induction of the
adaptive T cell responses to influenza virus infection. Interestingly,
while both RDC subsets can stimulate influenza specific CD4
+ T
cell responses with comparable efficiency, only the migrant
CD103
+ RDC subset (when isolated from the MLN of virus
infected animals) is capable of driving extensive proliferation and
full differentiation of naı ¨ve antigen specific CD8
+ T cells into
effector cells. Importantly, this CD103
+ RDC subset is the only
cell type capable of efficiently capturing non-infectious influenza
virions administered into the respiratory tract and presenting in
vivo processed antigen to naı ¨ve influenza specific CD8
+ T cells in
the MLN. Thus, this RDC subset may be unique in its capacity to
carrying out ‘‘cross-presentation’’ to CD8+ T cells of non-
infectious (particulate and soluble) antigens entering the respira-
tory tract and viral antigen from virally infected cells in the
respiratory tract.
As demonstrated here and elsewhere [18,19,40], several distinct
subsets of the RDC (as defined by cell surface marker expression)
can be identified in the normal/non-inflamed murine respiratory
tract. Two of these subsets, the CD103
+ and CD11b
hi DC, are
minimally represented in the LN draining the lower respiratory
tract, but CD103
+ and CD11b
hi DC did accumulate significantly
in the MLN following i.n. influenza infection. The tempo of the
CD103
+ and CD11b
hi DC accumulation, i.e. onset between 1 and
2 days p.i., paralleled the previously reported tempo of activation
of naı ¨ve CD8
+ T cell activation in the MLN following sub-lethal
influenza infection [7,8] suggesting a potential role for these
accumulating CD103
+ and CD11b
hi DC in T cell activation in the
MLN. At least 3 mechanisms could account for the accumulation
of these DC subsets in the MLN in response to respiratory
infections; 1. migration of CD103
+ and CD11b
hi RDC from the
respiratory tract to the MLN in response to infection; 2.
mobilization of blood-borne DC progenitors from the circulation
into the MLN in response to infection; 3. acquisition of these cell
surface markers by LN-resident DC in response to infection.
Multiple lines of evidence described in this report suggest that
the CD103
+ and CD11b
hi DC accumulating in the MLN are
indeed migrant RDC in the respiratory tract in response to virus
infection. Along with standard techniques of DC detection in the
MLN after uptake of dye and/or labeled antigen introduced into
the respiratory tract [7,23,41] and evaluation of recent cell division
by BrdU uptake and Ki- 67 expression, which argued for
terminally differentiated cells of respiratory tract origin as a source
of these DC accumulating in the MLN, we were unable to inhibit
the accumulation of these 2 DC subsets in the MLN by blocking
CD62L (not depicted) - a critical adhesion molecule for DC
migration from the circulation into secondary lymphoid organs
[9,11,42]. More importantly, we found that in DTR mice the
selective ablation of the CD11c
hi CD103
+ and CD11b
hi RDC
subsets by low dose DTx administration to the respiratory tract at
the time of respiratory virus infection selectively inhibited the
accumulation of CD103
+ and CD11b
hi DC in the MLN after
infection. Consistent with the result in DTR mice, CCR7
2/2
mice, which have a normal component of the CD103
+ and
CD11b
hi DC in the respiratory tract and require interaction
between CCR7 on activated DC with its chemokine ligands for
efficient migration to the DLN [5,34,43], also failed to accumulate
the CD103
+ and CD11b
hi DC in the inflamed MLN. In this
connection, it is particularly noteworthy that the substantially
diminished migration of the CD103
+ and CD11b
hi RDC to the
MLN in response to respiratory virus infection as a result of
depletion (DTx treatment) or absence of a response to a
chemotactic stimulus (CCR7
2/2 mice) also resulted in markedly
diminished naı ¨ve CD8
+ T cell activation in the MLN.
Although numerous studies have examined the impact of
introduction of inert antigens and infectious agents into the
respiratory tract on respiratory and LN DC properties and
function in the induction of adaptive immune responses
[7,41,44,45,46], the relative contribution of respiratory tract-
derived and LN-resident DC in driving T cell responses to
respiratory tract antigens or pathogens has been difficult to define.
Indeed, there is compelling evidence that migrant RDC may
function primarily in antigen transport and delivery to LN-resident
DC in the draining LN which in turn are largely responsible for
induction of adaptive T cell immune responses [22,41,44,45]. Our
findings on the effect of DTx ablation of RDC subsets and the
impact of CCR7 deficiency on DC accumulation and T cell
activation in the MLN could simply reflect the role of migrant
CD11c
hi CD103
+ and CD11b
hi RDC in antigen transport.
However, direct analysis of the capacity of DC subsets isolated
from the MLN of infected animals at the time of naive CD8
+ T
cell activation (d3 p.i.) to support naı ¨ve CD8
+ and CD4
+ T cell
activation reveals that the migrant CD103
+ and CD11b
hi RDC
isolated from the MLN are most efficient at stimulating naı ¨ve T
cells. The migrant Gr-1
+ MoRDC are much less efficient on a per
cell basis at stimulating naive T cells, particularly naı ¨ve CD8
+ T
cells. The cells are, however, the major migrant RDC subset
entering the draining MLN and can stimulate naı ¨ve CD4
+ T cells
with modest efficiency. Although Gr-1
+ MoDC had been
implicated as important APC for naı ¨ve T cell activation in several
models [12,13,14], our findings on the impact of low dose i.n. DTx
administration (as well as CCR7 deficiency) on the numbers and
migration of these inflammatory DC to the MLN during infection
suggest a minor role for these cells as APC at least in the
respiratory tract during natural virus infection.
Our ability to liberate the CD8aa
+ LNDC from the MLN in
significant numbers is critically dependent on the method of LN
disruption and DC isolation. Using enzymatic treatment of the
disrupted MLN, we isolated sufficient numbers of these cells from
the d3 p.i. draining MLN to examine their antigen presenting
activity for naı ¨ve CD8
+ T cells with minimal contamination by the
two other CD8a
+ DC subsets in the MLN (i.e., the migrant
CD103
+ and CD11b
hi RDC). We found that similar to migrant
Gr-1
+ MoDC the CD8aa
+ LNDC had modest antigen presenting
capacity. We cannot exclude the possibility that a fraction of the
LN CD8aa
+ DC upregulate MHC II at d3 p.i. and are including
among the sorted population of MHC II
hi migrant RDC. Thus
this subpopulation of CD8aa
+ DC could have potent antigen
presenting capacity like the migrant CD11b
hi RDC. Although our
results do not exclude an important role of CD8aa
+ LNDC in
antigen presentation to naı ¨ve T cells as shown by Belz et al. [7],
our findings suggest a major role for migrant RDC, especially
CD103
+ RDC, as the primary APC for naı ¨ve CD8 T cells
responding to respiratory virus infection. The aforementioned
study of Belz et. al. in the influenza model demonstrating both LN-
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response to flu infection did not, however, identify the nature of
migrant RDC. Our study does not exclude the possibility that
either or both subsets of migrant RDC – CD103
+ and CD11b
hi –
could transfer viral antigen to the LN-resident DC upon migration
into the MLN. Although we did not observe an efficient antigen
presentation by lymph node-resident CD8aa
+ DC following
influenza infection, factors such as virus strain, inoculum dose,
method of DC isolation, undoubtedly could explain differences in
the phenotype and APC activity of the DC observed by us and
other investigators. It is noteworthy that our findings also
complement a recent report [47] in which Langerin (Lg)
+ RDC
were shown to contribute to the CD8 T cell response to influenza
infection. We and others have observed that CD103
+ RDC are
also Lg
+ [19,48] (T. Kim and T. Braciale, unpublished
observation). Furthermore, our study suggests that the CD11b
hi
RDC not only serve as potent APC for naı ¨ve anti- viral CD4
+ T
cells but also may contribute to the induction of anti- viral CD8
+ T
cell responses albeit with a lower efficiency. How these two subsets
of RDC interact to orchestrate CD8/CD4 T cell response to
respiratory viral infection remains to be determined.
The CD103
+ and CD11b
hi RDC differ not only in their
anatomic localization, but also notably in their respective capacity
to present viral antigen to naı ¨ve CD8
+ T cells. This was most
clearly demonstrated by our observation that only the CD103
+
RDC subset in the MLN can efficiently capture, process and
present to naı ¨ve CD8
+ T cells non-infectious viral antigen (virions)
introduced into the respiratory tract. This result was unexpected as
this RDC subset in the lung does not express markers linked to DC
specialized for cross-presentation, e.g. CD8a [25,26] or mannose
receptor [49], not depicted). However, the intimate association of
the CD103
+ RDC subset with the mucosal epithelium [19] would
make these cells ideally suited to preferentially sample non-
replicating (soluble or particulate) antigens introduced onto the
mucosal epithelial surface.
We were able to detect expression of influenza NP in the
migrant RDC isolated from the MLN of infected mice suggesting
that a fraction of the migrant RDC found in the MLN were virally
infected. As reported by us for RDC isolated from the uninfected
lungs [31] the migrant CD103
+ RDC subset was most susceptible
to infection. As noted above migrant CD103
+ RDC were more
efficient than CD11b
hi RDC in triggering CD8
+ T cell activation/
proliferation and in driving effector T cell differentiation during
virus infection. We cannot, however, conclude that this increased
effectiveness of the CD103
+ RDC as APC is directly linked to their
infectibility, i.e. that direct infection of the RDC enhances their
potency as APC for naı ¨ve CD8
+ T cells. Only a small fraction of
the CD103
+ RDC in the nodes are infected. Since this DC subset
appears to pick up, process and present exogenous viral antigen
(Fig. 6D) to naı ¨ve CD8
+ T cells, the majority of the migrant
CD103
+ RDC, which are NP
2, probably (or indeed likely)
function as APC by uptake of viral antigen from virally infected
cells in the infected lungs prior to the migration to the MLN.
Similarly the ability of the CD103
+ RDC to preferentially
stimulates naı ¨ve CD8
+ T cells is unlikely to be directly related to
the localization of this RDC subset in the respiratory tract and
their accessibility of viral antigen, since both the CD103
+ and
CD11b
hi RDC can capture viral antigen produced by either
natural infection or vaccine installation in the respiratory tract and
efficiently present in vivo processed antigen to naive CD4
+ T cells.
Rather, the higher efficiency of the CD103
+ RDC subset to cross-
present particulate viral antigen vaccine or (as recently reported)
soluble proteins introduced into the respiratory tract [22] as well as
viral antigen produced during natural infection most likely reflects
elevated expression of components of the class I presentation
pathway selectively by CD103
+ RDC and/or unique adaptation of
this RDC subset for the uptake, processing and delivery of
processed antigen to MHC class I molecules [49,50] (T. Kim and
T. Braciale, Manuscript in preparation). While differences in the
efficiency of processed peptide/MHC I complex formation and
consequently the strength of signal delivered to the TCR by these
2 RDC subsets could explain the ability of the CD103
+ RDC to
more efficiently drive the development of CD8
+ T cell effector
function, we believe that the CD103
+ and CD11b
hi RDC subsets
may also differ in their capacity to deliver accessory signals
necessary to drive CD8
+ T effector cell differentiation.
The CD103
+ and CD11b
hi RDC continued to increase in
numbers in the MLN for up to 5 days p.i. In parallel, there was a
corresponding large influx of Gr-1
+ MoDC. These CD11c
loF4/
80
+MHC II
lo DC are present at the minimal levels in the normal
respiratory tract and MLN. They presumably arose from
circulating Gr-1
+ monocyte progenitors which entered the
respiratory tract in response to infection. These Gr-1
+ MoDC
which, as demonstrated here, can capture antigens and then
migrate by a CCR7-independent mechanism to the MLN have
been reported to act as APC [12,13,14,51]. These migrant Gr-1
+
MoDC in the MLN appear, however, to have minimal capacity to
present viral antigen to T cells and only to CD4
+ T cells. Elevated
numbers of all 3 of these migrant RDC populations are detectable
in the MLN out to at least d10 p.i. Since the capacity of DC in the
MLN to stimulate naı ¨ve T cells is markedly diminished by d10 p.i.
[7] (T. Kim and T. Braciale, Manuscript in preparation), the
reason for the elevated numbers of these migrant RDC in the
MLN after virus clearance [52] remains to be determined,
although they may play a role as APC in memory T cell
generation [53,54] (Kim and Braciale, Manuscript in preparation).
In conclusion, we have demonstrated that several distinct
subsets of RDC migrate to the LN draining the respiratory tract in
response to influenza virus infection. Our results indicate that
antigen presenting capacity resides predominantly, if not exclu-
sively, with the migrant RDC and only 2 of these migrant RDC
subsets (i.e., the CD103
+ and CD11b
hi DC) can efficiently activate
naı ¨ve antigen-specific T cells in the MLN in response to infection.
The ability of the CD103
+ RDC subset to preferentially present
antigen to CD8
+ T cells both during infection and after viral
vaccine instillation into the respiratory tract, along with the
localization of this RDC subset within the airway mucosa, makes
this DC subset a potentially important candidate cell type for
further analysis in the study of respiratory disease pathogenesis and
in mucosal vaccine development.
Materials and Methods
Mice
Female BALB/c mice (H-2
d) were purchased from the Taconic
Farms (Germantown, NY). Transgenic (Tg) mice expressing non-
human primate Diphtheria Toxin Receptor (DTR) under the
control of the murine CD11c-promoter (C.FVB-Tg
Itgax-DTR/EGFP
57Lan/J, H-2
d) mice and Thy-1.1 Clone 4 (Cl-4) TCR Tg mice
(H-2
d) were obtained from The Jackson Laboratory (Bar Harbor,
ME). Thy-1.2 Cl-4 TCR Tg mice (H-2
d) were a generous gift from
Dr. R.W. Dutton (Trudeau Institute, Saranac Lake, NY). Thy-1.2
TS1 TCR Tg mice (I-A/E
d) were kindly provided by Dr. A. Caton
(Wistar Institute, PA). Mice deficient in chemokine receptor CCR7
(CCR7
2/2) have been described [5] and kindly provided by Dr.
C. Rose (University of Virginia, VA). These mice were bred and
housed in a pathogen-free environment and used at 9–13 wks of
age for all experiments. To delete CD11c
+ cells, DTR Tg mice
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experiments were performed in accordance with protocols
approved by the University of Virginia Animal Care and Use
Committee.
Infection of mice
Type A influenza virus, A/PR/8/34 (H1N1), was grown in day
10 chicken embryo allantoic cavities as described previously [8].
Mice were infected either i.n. (in 50 ml) with 350 egg infectious
doses (EID) or intravenously (in 500 ml) via tail vein with 1.7610
7
EID. Inactivation of infectious influenza virus was prepared by
UV-crosslinking as described previously [55]. After UV exposure
of the virus suspension is complete, the samples are serially diluted
10-fold and determined for infectivity using plaque assay in
MDCK cells. The non-infectious virus is delivered i.n. at 1.7 ng/
ml in 50 ml.
Intranasal instillation of FITC-ovalbumin
Mice were given i.n. either FITC-conjugated ovalbumin (FITC-
Ova, 1 mg in100 ml, Moleular Probes, Eugene, OR) or unlabeled
Ova (1 mg in100 ml, Sigma) as a control. The amounts of FITC-
Ova taken by lung cells in uninfected mice were assessed at 1 hr
post-instillation by flow cytometry and compared to unlabeled
Ova. In infected mice, FITC-Ova or Ova proteins were i.n.
instilled at d2 p.i. FITC
+ cells in the lung-draining MLN or spleens
were examined at 24 hr later.
Preparation of tissue leukocytes
Preparation of lung single cell suspensions after enzymatic
digestion were described elsewhere [27]. Briefly, Mice were
sacrificed and lungs were perfused via the right ventricle of the
heart with 5 ml sterile PBS to remove the intravascular pool of
cells from the lung vasculature. The tissues were minced and then
digested in 183 U/ml Type II collagenase (Worthington, Lake-
wood, NJ) in IMDM (Invitrogen, Gaithersburg, MD) at 37uC for
30–40 minutes. Afterwards, lung tissues were passed though a wire
screen. Single cell suspensions from LN and spleens were prepared
by mashing through 70 mM Cell Strainer (BD) without enzymatic
digestion. Red Blood Cells (RBC) in the cell suspensions were lysed
using ammonium chloride. Cells were washed and resuspended in
FACS buffer containing 16 PBS, 2% FBS, 10 mM EDTA and
0.01% NaN3 for Ab staining or MACS buffer containing 16PBS,
2% FBS and 10 mM EDTA for sorting. Viable nucleated cells in
the suspensions were counted using a hemacytometer after
exclusion of dead cells using Trypan blue dye.
T cell and DC isolation
For CD8
+ or CD4
+ T cell isolation, cell suspensions from spleens
were isolated using a CD8 or CD4 T cell isolation kit, according to
the manufacturer’s protocol (Miltenyi Biotec). For DC isolation
from LN (n=30–35 mice/sorting), CD11c
+ cells were enriched by
negative selection after incubation with a mix of specific mAbs
(FTIC-conjugated mAbs againstCD19,DX5and TCRb),andanti-
FITC magnetic microbeads using MACS cell sorter (Miltenyi
Biotec) in accordance with the manufacturer’s instruction. The
enriched populations were stained with a cocktail of mAbs specific
to I-A
d, CD103, CD11c, B220, and CD11b and sorted for
CD11c
+B220
+MHC II
low (pDC), CD11c
+B220
2CD11b
hiMHC
II
int (Gr-1
+ MoDC), CD11
+B220
2MHC II
hiCD11b
+CD103
2
(CD11b
hi DC) or CD11c
+B220
2MHC II
hiCD103
+ (CD103
+ DC)
(see Fig. S9) by flow cytometry using a FACSVantage SE Turbo
sorter at the Flow Cytometry Core Facility (University of
Virginia).
In vitro DC:T cell co-cultures
The culture medium used for DC:T cell cultures was RPMI
1640 supplemented with 10% heat-inactivated FCS, 1% Sodium
Pyruvate, 2 mM L-glucose, 20 mM HEPES, 5 mM b-mercap-
toenthanol and 100 mg/ml Gentamycin (all from Invitrogen). For
DC:T cell cultures, 1610
4 DCs and 1610
5 T cells were cultured
in a volume of 200 ml in round-bottomed 96-well plates (Corning)
and incubated at 37uC for 4 days in RPMI 1640 media. Peptide-
coated DC were prepared by incubating isolated DC with 1 mM
peptide (HA533–541) for 1 hr at 37uC, followed by 26 washes to
remove any free peptides prior to co-culture with T cells.
Adoptive transfer
Purified splenic naive CL-4 Tg CD8
+ T cells were labeled with
carboxyfluorescein diacetate succinimidyl ester (CFDA-SE; Mo-
lecular Probes, Eugene, OR) as previously described[8]. A total of
1–5610
6 CFSE-labeled CD8
+ T cells were i.v. injected into the
tail vein of Thy-mismatched congenic mice. Recipient mice were
infected with influenza virus 24 hr later.
Antibodies
The following monoclonal antibodies (mAb) were purchased
from BD-Biosciences (BD) (San Diego, CA) or eBiosciences (eBio)
(San Diego, CA) (unless stated), as conjugated to FITC, PE, PE-
Cy7, PerCP-Cy5.5, APC, APC-Alexa740 or Biotin: MHC class II
(I-A
d, AMS-32-1), MHC class I (H-2K
d, SF1-1.1), Gr-1 (RB6-
8C5), TCRb (H57-597), CD1d (1B1), CD4 (L3T4), CD8a (53-
6.7), CD11a (2D7), CD11b (M1/70), CD11c (HL3), CD19 (1D3),
CD40 (3/23), CD43 (S7), CD43 (1B11), CD45 (30-F11), B220 or
CD45R (RA3-6B2), CD80 (16-10A1), CD83 (Michel 17), CD86
(GL-1), CD115 (AFS98), DX5 (HMa2), B7-H1 (MIH5), B7-DC
(TY25), b7 integrin (M293), ICOSL or B7-H2 (HK5.3),
Granzyme B (GB12, Caltag), IFN-c (XMG1.2), TNF-a (MP6-
XT22), IL-4 (BVD4-1D11), IL-10 (JES5-16E3),Ki-67 (MOPC-
21), CCR7 (EBI-1), SiglecF (E50-2440), F4/80 (Cl:A3, Caltag),
CD103-Alexa-Fluor-647 (2E7, Biolegend, San Diego, CA),
mPDCA (Miltenyi Biotec, Auburn, CA), isotype control antibod-
ies. Anti-mouse CD16/32 used for Fc receptor blocking was
isolated and purified in our laboratory. For biotinylated mAbs,
samples were incubated with streptavidin (SA)-RPE, SA-APC or
SA-APC-Cy7.
Flow cytometry analysis and intracellular staining
Cell suspensions were blocked with 2.4G2 and then incubated
with specific mAbs or isotype controls for 25 min on ice. For
surface marker staining, cells were fixed in FACSLysing Solution
(BD). For intracellular cytokine staining, cells obtained from in vitro
cultures were incubated for 4–5 hr with synthetic peptide (HA533–
541) for CD8
+ T cells with Thy-mismatched splenocytes as an
additional APC or with 50 ng/ml PMA and 750 ng/ml
Ionomycin (both from Sigma) for CD4
+ T cells in the presence
of monensin (BD) in a tissue culture incubator at 37uC. After
surface staining for 25 min with the corresponding cocktail of
fluorescently labeled antibodies, cells were resuspended in
Cytofix/Cytoperm solution (BD), and intracellular cytokine
staining was performed according to the manufacturer’s protocol.
Granzyme B was detected directly after surface staining. For the
detection of nucleocapsid (NP) viral protein, mouse monoclonal
anti-NP antibody (clone H16, a gift from Dr. Walter Gerhard,
Wistar institute, PA) was conjugated to Alexa-555 (Molecular
Probe, Eugene, OR) according to the manufacturer’s instruction
and used to intracellularly stain for NP. For Ki-67 staining,
surface-stained cells initially were fixed in 16 FACSLysing
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(BD) for 15 min at room temperature (RT). The fixed/
permeabilized cells were incubated with PE-labeled anti-Ki-67
or isotype-matched mAbs (BD) for an additional 30 min at RT.
Flow cytometry was performed on either FACSCalibur or
FACSCanto flow cytometers (BD, Mountain View, CA), and
data were analyzed using Flowjo (Tree star).
BrdU labeling and detection
Mice were given 1 mg/250 ml BrdU by i.p. injection on the day
of influenza virus infection and continuously fed in drinking water
(0.4 mg/ml) with daily changes. Tissue cells were prepared for cell
surface antibody Ab labeling and BrdU staining was performed
using the BD FastImmune BrdU kit according to the manufac-
turer’s instructions (BD).
Statistics
A two-tailed unpaired Student t test was used to analyze
differences in mean values between groups. These statistical
analyses were performed using the GraphPad Prism3 Software
Program for Macintosh. All results are expressed as means6SD.
Values of P,0.05 were considered statistically significant.
Supporting Information
Figure S1 Characterization of CD11c+ cells in the normal lung.
(A) Flow cytometry-based categorization of RDC subpopulations.
Hematopoietic origin cells in the lung suspensions (panel a) are
identified as CD45+ (panel b). Among the CD11c+ cells (panel c),
the highly auto-fluorescent alveolar macrophages (AM)
[SSChiMHC II2 (panel d)] and B220+ plasmacytoid DC (pDC
- mPDCA-1+Gr-1+, panel e) are excluded from further analyses.
The remaining lung leukocytes are further divided into three
subsets; CD103+ RDC (panel f), CD103-CD11bhiMHC II+/2
(MoRDC, panel g) and CD103-CD11bhiMHC IIhi (CD11bhi
RDC, panel h). (B) Identification of AM in the lung. Single cell
suspensions from normal lung are stained with a cocktail of mAbs
specific to CD45, CD11c, SiglecF and MHC II. CD45+CD11c+
cells are examined for SigecF expression (top panel) and SSC
property (bottom panel) along with MHC II expression. (C)
Diagrams depicting the cellular composition of the CD11c+ cells
in the single cell lung suspensions (mean6SD; n=5). (D) Surface
marker expression on subsets of RDC. Lung-residing DC subsets –
CD103+ RDC (top), CD11bhi RDC (middle), and MoRDC
(bottom) – are examined at d0 (open) or d2 p.i. (gray) for surface
expression of various markers tested. Vertical lines (%) indicate the
median values of isotype-matched control antibodies (black) for
surface marker staining.
Found at: doi:10.1371/journal.pone.0004204.s001 (18.84 MB
TIF)
Figure S2 Strategy for identifying DC subsets in the MLN
draining lung. (A–C) Gating strategy for identifying DC subsets in
the MLN of uninfected or influenza-infected mice. Total leukocytes
isolated fromtheMLN ofuninfected (column A)ori.n.infected wild
type (wt, column B) or B cell-deficient (mMT, column C) mice at d3
p.i. are stained with a cocktail of mAbs specific to TCRb, CD11c,
CD11b, B220, CD103 and MHC II. T cells are first gated out to
discriminate CD11c+ cells (row i). Subsequently, TCRb-CD11c+
cells (row ii) are further analyzed for B220 vs MHC II expression,
which results in the identification of pDC (B220+MHC II-
loGr21+CD192) as well as B cells (B220+MHC IIhiGr-1-
CD19+) (row iii). TCRb-CD11c+B2202 cells (row iii) are further
examined forCD11b vs MHCII expression, dividing them into two
groups: MHC II2/lo and MHC IIhi (row iv). Cells within MHC
II2/lo fraction can be classified into Gr-1+ MoDC (group III) and
Gr-12 MoDC (row v). Lastly, cells expressing high levels of MHC
II are further divided into two subgroups based on CD103 and
CD11b expression; CD11bhiCD1032 cells identified as ‘CD11bhi
DC’ (group II) and CD11b+/2CD103+ cells as ‘CD103+ DC’
(group I).
Found at: doi:10.1371/journal.pone.0004204.s002 (11.48 MB
TIF)
Figure S3 Identification and phenotypic characteristics of LN-
resident CD8aa+ DC. Total LN cells were liberated, after
enzymatic digestion, from the MLN of infected mice at indicated
days post infection with influenza virus as previously described
[2,7]. The liberated single cell suspensions were stained with a
cocktail of mAbs specific to CD11c, CD11b, CD103, CD8a and
MHC II (A) or accessory surface markers (B). (A) CD11chiMHC
IIint (R1) were examined for the expression of CD8a and CD11b.
The CD8ahi population in R1 gates, representing the authentic
LN-resident CD8aa+ DC subset, are identified in the node of
uninfected and infected animals. CD11cmed-hi MHC IIhi (R2)
are also examined for their expression of either CD8a and CD11b
or CD103 and CD11b. Of note, CD8a expressing CD103+ and
CD11bhi DC subsets in R2 gates gradually increased as infection
progressed (compare 3 dpi to 0 dpi). (B) The CD8aa+ LNDC
express higher levels of CD8a and CD11c and lower levels of
CD80, CD83, CD86, B7-H1, B7-DC and MHC II than those of
CD103+ or CD11bhi DC in the MLN of infected mice when
analyzed at d3 p.i.
Found at: doi:10.1371/journal.pone.0004204.s003 (5.31 MB TIF)
Figure S4 Morphologic and phenotypic characteristics of DC
subsets in the MLN of infected mice. DC subsets accumulating in
the MLN of influenza-infected mice at d3 p.i. are identified as
described in the Figure S2 and examined for their size (FSC),
intracellular complexity (SSC), and surface maker expression after
staining with the indicated mAbs.
Found at: doi:10.1371/journal.pone.0004204.s004 (2.76 MB TIF)
Figure S5 Active viral nucleoprotein synthesis in infected
CD103+ RDC in vitro and in vivo. (A) CD103+ RDC were
single-cell sorted from uninfected lungs and incubated with A/
PR/8 for 1 hr in vitro. After additional 18 hrs of incubation, the
CD103+ RDC were fixed and examined for intracellular
expression of MHC II (green, left) and viral NP (red, right) under
confocal microscope. (B) A/PR/8-infected mice were given i.n.
FITC-Ova at d2 p.i., and MLN were excised at d3 p.i. and frozen
for immunofluorecence study. Migrant CD103+ RDC (NP+ and
FITC-Ova+) in the MLN were identified by Flow cytometry (See
Figure 3 A and B) and examined for intracellular expression of NP
(red) under confocal microscope.
Found at: doi:10.1371/journal.pone.0004204.s005 (12.15 MB
TIF)
Figure S6 Accumulation of CD11bhi DC and CD103+ DC in
the MLN of influenza-infected mice is as a result of the emigration
of the corresponding counterparts in the lung, and is dependent on
CCR7. (A) Cell division history of DC subsets in the MLN of
infected mice. Mice were i.n. infected with influenza virus and
given BrdU in drinking water while during the 3 d infection period
(controls without BrdU in gray). A representative analysis of %
BrdU+ DC subsets in MLN is shown (n=4). (B) Lung-residing
CD11bhi and CD103+ RDC are necessary for the accumulation
of the corresponding DC subsets in the MLN of influenza-infected
mice. DTR mice are i.n. administered with either DTx or PBS one
day prior to i.n. influenza virus infection. At d3 p.i., DC subsets in
the MLN of infected mice are identified (see Fig. 4E), and the
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of infected DTR mice are depicted (mean6SD; n=4–8 mice/
group). (C and D) CCR7-deficient mice failed to show the
accumulation of CD11bhi DC and CD103+ DC, but not Gr-1+
MoDC, in the MLN of influenza-infected mice. CCR7+/+ or
CCR72/2 mice i.n. infected 3 d earlier with influenza virus are
examined for the accumulated DC subsets in the MLN of infected
mice. Identification (C) and the numbers of DC subsets and total
cellularity (D) in the MLN of infected mice are depicted
(mean6SD; n=3–5 mice).
Found at: doi:10.1371/journal.pone.0004204.s006 (12.90 MB
TIF)
Figure S7 Tempo of the antigen-specific naı ¨ve CD8+ T cell
proliferation in the MLN of infected mice. Mice (Thy1.1) received
CFSE-labeled Thy1.2 CL-4 CD8+ T cells were i.n. infected with
influenza virus and examined for the proliferation profiles (dilution
of CFSE contents) of naı ¨ve CL-4 CD8+ T cells in the MLN at
indicated days p.i. Data shown are gated on Thy1.2+ CD8+ T
cells.
Found at: doi:10.1371/journal.pone.0004204.s007 (0.36 MB TIF)
Figure S8 CCR7-deficient mice are impaired in supporting the
proliferative expansion of CCR7-competent naı ¨ve CL-4 tg CD8+ T
cells. (A) CCR72/2 mice (Thy1.2) received CFSE-labeled Thy1.1
CCR7+/+ CL-4 CD8+ T cells were i.n. infected 4 days earlier, and
the magnitude of expansion and dilution of CFSE contents in naive
CL-4 CD8+ T cells in the MLN are examined. Data shown are
gated on Thy1.1+ CD8+ T cells, and a representative of 3
independent experiments is depicted. (B) CCR7 deficiency on host
LNDC exhibits a comparable capability to activate CCR7-
competent donor naive CD8 T cells compared to CCR7+/+
LNDC when influenza virus were delivered via intravenous route.
WT or CCR72/2 mice were received CFSE-labeled Thy-
mismatched CCR7+/+ A/PR/8 HA-specific TCR tg naive CD8
T cells and infected with A/PR/8 via intravenous route 24 hr later.
The division profiles and proliferative expansion of the HA-specific
CD8 T cells in the MLNs and spleens were examined at d3 p.i.
Found at: doi:10.1371/journal.pone.0004204.s008 (3.05 MB TIF)
Figure S9 A 4-way cell sorting of DC subsets in the MLN of
infected mice. (A–D) Single cells are prepared from the MLN of
i.n. infected mice 3 days earlier with influenza virus. To enrich
CD11c+ cells from the total leukocytes in the MLN, T, B and NK
cells are depleted using a cocktail of magnetic beads directed at
TCRb, CD19 or DX5 as described in Materials and Methods.
The resulting fraction containing the enriched CD11c+ cells is
surface-stained with a cocktail of mAbs specific for CD11c, B220,
CD11b, CD103, or MHC II, and subjected to a FACS-based 4-
way cell sorting. DCs are identified by CD11c expression. The
CD11c+ cells are initially displayed for B220 vs MHC II for
identifying B220+ pDC (A). The B220-CD11c+ cells are then
displayed for CD11b vs MHC II, which results in two distinct
populations based on the level of MHC II expression;
CD11bhiMHC IIlo vs CD11blo-hiMHC IIhi cells. The former
is mainly composed of Gr-1+ DC (see Fig. S2) and sorted as Gr-1+
MoDC (B). Afterwards, the MHC IIhi cells are further divided
into two groups based on CD103 expression; CD1032 DC (C) vs
CD103+ DC (D). MHC IIhiCD1032 cells are also largely
CD11bhi cells and sorted as CD11bhi DC (C). Purity of the sorted
cells is determined by flow cytometry using the respective subsets
of post-sorted DC, which results in greater than 97% of
homogeneity in all experiments (right panels).
Found at: doi:10.1371/journal.pone.0004204.s009 (5.38 MB TIF)
Figure S10 Proliferation of CL-4 CD8+ T cells stimulated by
peptide-pulsed either pDC or Gr-1+ MoDC. (A and B) B220+
pDC (A) or Gr-1+ MoDC (B) are sorted from the MLN of infected
mice 3 days earlier with infectious influenza virus and pulsed with
HA533–541 peptide (open) or left untreated (filled) for 1 hr. pDC
or Gr-1+ MoDC are then co-cultured with CFSE-labeled naı ¨ve
CL-4 CD8+ T cells in culture. At day 4 the dilution of CFSE
contents in CL-4 CD8+ T cells is examined by flow cytometry. A
representative of 3 independent experiments is depicted.
Found at: doi:10.1371/journal.pone.0004204.s010 (1.34 MB TIF)
Figure S11 Effector cytokine production of CD4+ T cells
stimulated by either CD11bhi or CD103+ DC subsets. (A–C)
CD11bhi DC (top panel) and CD103+ DC (lower panel) in the
MLN of i.n. infected mice 3 days earlier with infectious influenza
virus are sorted and co-cultured with CFSE-labeled HA-specific
naı ¨ve TCR tg TS1 CD4+ T cells in culture. Four days later, CD4+
T cells are restimulated with PMA/ionomycin for an additional
4 hr in the presence of monensin and intracellularly stained for
IFN-c (A), IL-4 (B) or IL-10 (C) secretion. A representative of 3
independent experiments is depicted.
Found at: doi:10.1371/journal.pone.0004204.s011 (2.01 MB TIF)
Figure S12 CD8aa+ LNDC are less efficient than migrant
CD103+ and CD11bhi RDC at stimulating naı ¨ve virus specific
CD8+ T cells. (A) The indicated DC subsets were isolated, after
enzymatic treatments, from the MLN of mice infected 3 d earlier
with influenza virus (A/PR/8) [i.e., Gr-1+ MoDC (i), LN-resident
CD8aa+ DC (ii), CD11bhi DC (iii) and CD103+ DC (iv)]. The
DC subsets were co-cultured with CFSE-labeled HA533–541 (A/
PR/8/34)-specific naı ¨ve TCR tg CD8+ T cells (Cl-4) for 4 days.
Proliferation profile and total recovery (see inserts) of viable CD8+
T cells stimulated by the MLN-derived DC subsets are depicted.
(B) As a control in companion experiments, the DC subsets used in
(A) were pulsed with HA210–219 (A/JAPAN/57) and were
subsequently co-cultured for 4 days with CFSE-labeled HA 210–
219-specific naı ¨ve TCR tg CD8+ T cells (Demi-4). These CD8+
TCR tg T cells do not cross-react with the A/PR/8/34
hemagglutinin.
Found at: doi:10.1371/journal.pone.0004204.s012 (7.09 MB TIF)
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